Cargando…
Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice
Substrates of semicarbazide-sensitive amine oxidase (SSAO) exert insulin-like actions in adipocytes. One of them, benzylamine (Bza) exhibits antihyperglycemic properties in several rodent models of diabetes. To further study the antidiabetic potential of this naturally occurring amine, a model of se...
Autores principales: | Iffiú-Soltesz, Zsuzsa, Wanecq, Estelle, Tóthfalusi, László, Szökő, Éva, Carpéné, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401126/ https://www.ncbi.nlm.nih.gov/pubmed/34444782 http://dx.doi.org/10.3390/nu13082622 |
Ejemplares similares
-
Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue
por: Mercader, Josep, et al.
Publicado: (2011) -
Hyperglycemia and reduced adiposity of streptozotocin-induced diabetic mice are not alleviated by oral benzylamine supplementation
por: Carpéné, Christian, et al.
Publicado: (2022) -
Effects of Chemical Structures Interacting with Amine Oxidases on Glucose, Lipid and Hydrogen Peroxide Handling by Human Adipocytes
por: Carpéné, Christian, et al.
Publicado: (2022) -
Early Hepatic Insulin Resistance Precedes the Onset of Diabetes in Obese C57BLKS-db/db Mice
por: Davis, Richard C., et al.
Publicado: (2010) -
Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice
por: Li, Hong-Qin, et al.
Publicado: (2022)